SCHEMBL30830652

SCHEMBL30830652

Cc1cc(OC2CCN(C(=O)c3ccc([C@H]4C[C@@H](Nc5cnn(C)c(=O)c5Br)CN(C)C4)cc3)CC2)ccc1C1CCC(=O)NC1=O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 11/20 0.48
▸ BRD9 Q9H8M2 3/20 0.48
▸ BRD1 O95696 1/20 0.48
▸ ACHE P22303 1/20 0.48
▸ BRPF1 P55201 1/20 0.48
▸ BPTF Q12830 1/20 0.48
▸ KAT2A Q92830 1/20 0.48
▸ BRD7 Q9NPI1 1/20 0.48
▸ BAZ2B Q9UIF8 1/20 0.48
▸ BRPF3 Q9ULD4 1/20 0.48
▸ HRH3 Q9Y5N1 3/20 0.32
▸ PROKR1 Q8TCW9 1/20 0.32
▸ FASN P49327 1/20 0.32
▸ DDB1 Q16531 2/20 0.32
▸ CRBN Q96SW2 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ MTHFD1 P11586 1/20 0.31
▸ MTHFD2 P13995 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30830638 0.95 KAT2B (0.48) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830570 0.92 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830729 0.91 KAT2B (0.52) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830585 0.88 KAT2B (0.48) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830819 0.88 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830937 0.87 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830693 0.87 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830614 0.87 KAT2B (0.53) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830684 0.86 KAT2B (0.56) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830680 0.86 KAT2B (0.54) KAT2BBRD9BRD1ACHEBRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback